Neomycin

CAT:
804-HY-150520
Size:
Inquire
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Neomycin - image 1

Neomycin

  • UNSPSC Description:

    Neomycin is an aminoglycoside antibiotic. Neomycin can be used for the research of external or internal bacterial infections, is primarily administered in veterinary medicine as a sulfate salt[1].
  • Target Antigen:

    Antibiotic
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Infection; Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/neomycin.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    [Neomycin]
  • References & Citations:

    [1]Liu Y, et al. Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine. J Vet Pharmacol Ther. 2021 Sep;44(5):850-853.Genome Biol. 2023 Apr 30;24(1):98.|J Agric Food Chem. 2024 Apr 10.|Neoplasia. 2024 Jan 3:47:100963.|Neural Regen Res. 2024 Sep 1;19(9):2081-2088.|Am J Chin Med. 2024 Aug 21:1-28.|Aquaculture. 2021, 736248.|Biochem Pharmacol. 2024 Oct 23:116593.|Brain Behav Immun. 2020 Nov 24;S0889-1591(20)32408-9.|Cancer Immunol Res. 2022 Dec 2;10(12):1542-1558.|Cell Death Dis. 2021 Jun 7;12(6):582.|Cell Death Discov. 2022 Feb 22;8(1):77.|Cell Metab. 2023 Sep 29:S1550-4131(23)00340-6.|Cell Metab. 2024 Sep 28:S1550-4131(24)00366-8.|Cell Rep Med. 2024 Sep 21:101753.|Cell Rep. 2021 Sep 7;36(10):109660.|Cell Rep. 2023 Dec 27;43(1):113591.|Clin Transl Med. 2024 Oct;14(10):e70038.|EMBO Rep. 2024 Sep 27.|Emerg Microbes Infect. 2022 Feb 22;1-34.|Front Aging Neurosci. 2022 Jul 28;14:858130.|Gut Microbes. 2023 Dec;15(2):2249143.|Gut Microbes. 2023 Dec;15(2):2282790.|Gut Microbes. 2024 Jan-Dec;16(1):2390164.|Int J Biol Macromol. 2024 Sep 19:135835.|J Cell Physiol. 2021 Dec 8.|J Nanobiotechnology. 2024 Apr 8;22(1):157.|J Pineal Res. 2024 Apr;76(3):e12954.|Life Sci. 2020 Nov 15;261:118473.|Microbiologyopen. 2019 Oct;8(10):e873.|Mol Cell Biochem. 2021 Jun;476(6):2503-2512.|Mol Immunol. 2022 Jul 6;149:94-106.|Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct 1.|Neurotherapeutics. 2023 Aug 18.|NPJ Biofilms Microbiomes. 2024 Oct 28;10(1):111.|Nutrients. 2023 Oct 18, 15(20), 4427.|Pharmacol Res. 2024 May 21:205:107229.|Res Sq. 2024 Oct 02.|Research (Wash D C). 2024 Jul 16:7:0415.|Sci Adv. 2023 Feb 17;9(7):eade4770.|SSRN. 2023 Sep 11.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    Launched
  • CAS Number:

    1404-04-2